LASA.NS
Price:
$12.92
Market Cap:
$647.31M
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-09-21
Stock Exchange
NSE
Ticker
LASA.NS
According to Lasa Supergenerics Limited’s latest financial reports and current stock price. The company's current ROE is -16.31%. This represents a change of 275.05% compared to the average of -4.35% of the last 4 quarters.
The mean historical ROE of Lasa Supergenerics Limited over the last ten years is -5.70%. The current -16.31% ROE has changed 186.14% with respect to the historical average. Over the past ten years (40 quarters), LASA.NS's ROE was at its highest in in the March 2022 quarter at 7.78%. The ROE was at its lowest in in the March 2025 quarter at -17.07%.
Average
-5.70%
Median
-1.69%
Minimum
-32.65%
Maximum
14.33%
Discovering the peaks and valleys of Lasa Supergenerics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 14.33%
Minimum Annual Increase = -208.64%
Minimum Annual ROE = -32.65%
Year | ROE | Change |
---|---|---|
2025 | -17.63% | -21.57% |
2024 | -22.48% | -31.16% |
2023 | -32.65% | 866.92% |
2022 | -3.38% | -123.56% |
2021 | 14.33% | 458.82% |
2020 | 2.56% | -122.45% |
2019 | -11.43% | -208.64% |
2018 | 10.52% | 236.27% |
2017 | 3.13% | Infinity% |
The current ROE of Lasa Supergenerics Limited (LASA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-24.25%
5-year avg
-12.36%
10-year avg
-5.70%
Lasa Supergenerics Limited’s ROE is less than Lincoln Pharmaceuticals Limited (12.95%), less than Mangalam Drugs & Organics Limited (4.63%), less than Ind-Swift Laboratories Limited (24.69%), less than Krebs Biochemicals & Industries Limited (20.50%), less than Hester Biosciences Limited (8.92%),
Company | ROE | Market cap |
---|---|---|
12.95% | $11.17B | |
4.63% | $1.41B | |
24.69% | $6.38B | |
20.50% | $1.81B | |
8.92% | $15.24B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lasa Supergenerics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lasa Supergenerics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lasa Supergenerics Limited's ROE?
How is the ROE calculated for Lasa Supergenerics Limited (LASA.NS)?
What is the highest ROE for Lasa Supergenerics Limited (LASA.NS)?
What is the 3-year average ROE for Lasa Supergenerics Limited (LASA.NS)?
What is the 5-year average ROE for Lasa Supergenerics Limited (LASA.NS)?
How does the current ROE for Lasa Supergenerics Limited (LASA.NS) compare to its historical average?